Fibrocor Therapeutics

About:

Fibrocor Therapeutics focuses on developing disease modifying therapeutics in fibrosis.

Top Investors: BioGeneration Ventures, Toronto Innovation Acceleration Partners

Description:

Fibrocor Therapeutics is focused on developing disease modifying therapeutics in fibrosis.The company has already identified a lead program and will partner with Evotec to develop novel molecules .

Total Funding Amount:

2.8M CAD

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Toronto, Ontario, Canada

Founded Date:

2017-01-01

Founders:

Darren Yuen, Jeff Wrana, Richard E. Gilbert

Number of Employees:

1-10

Last Funding Date:

2020-01-01

IPO Status:

Private

Industries: